[1] 鲁雅娟, 张秀, 王佩娟. 王佩娟教授治疗卵巢储备功能低下常用药对[J]. 吉林中医药, 2016, 36:1211-1213.
[2] Green DM, Sklar CA, Jr B J, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment:results from the childhood cancer survivor study[J]. J Clin Oncol, 2009, 27:2374-2381.
[3] Krotz SP, Robins JC, Ferruccio TM, et al. In vitro maturation of oocytes via the pre-fabricated self-assembled artificial human ovary[J]. J Assist Reprod Genet, 2010, 27:743-750.
[4] 张婷, 王晓民. 解读《时代》周刊2010年度十大医学突破[J]. 首都医科大学学报, 2011, 32:159-163.
[5] Amorim CA, Shikanov A. The artificial ovary: Current status and future perspectives[J]. Future Oncol, 2016, 12:2323-2332.
[6] Donnez J, Dolmans MM. Fertility preservation in women[J]. Nat Rev Endocrinol, 2017, 377:1657-1665.
[7] 关毅.3D打印卵巢结构重塑小鼠的生育能力[J].自然杂志,2017,39:172.
[8] Laronda MM, Rutz AL, Xiao S, et al. A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice[J]. NatCommun, 2017:15261-15270.
[9] Seybold D, Schildhauer TA, Gessmann J, et al. Osteogenic differentiation of human mesenchymal stromal cells is promoted by a leukocytes containing fibrin matrix[J]. Langenbecks Arch Surg, 2010, 395:719-726.
[10] Li Y, Meng H, Liu Y, et al. Fibrin gel as an injectable biodegradable scaffold and cell carrier for tissue engineer-ing[J]. Scientific World Journal, 2015, 2015:685690.doi:10.1155/2015/685690.
[11] Luyckx V, Dolmans MM, Vanacker J, et al. First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary[J]. J Ovarian Res, 2013, 6:83-92.
[12] Sun J, Tan H. Alginate-based biomaterials for regenera-tive medicine applications[J]. Materials, 2013, 6:1285-1309.
[13] Lin HK, Madihally SV, Palmer B, et al. Biomatrices for bladder reconstruction[J]. Adv Drug Deliv Rev, 2015:47-63.
[14] Schmidt VM, Isachenko V, Rappl G, et al. Comparison of the enzymatic efficiency of Liberase TM and tumor dissociation enzyme: Effect on the viability of cells digested from fresh and cryopreserved human ovarian cortex[J]. J Biomed Mater Res, 2018, 16:57-70.
[15] Chiti MC, Dolmans MM, Hobeika M, et al. A modified and tailored human follicle isolation procedure improves follicle recovery and survival[J]. J Ovarian Res, 2017, 10:71-79.
[16] Chiti MC, Dolmans MM, Orellana O, et al. Influence of follicle stage on artificial ovary outcome using fibrin as a matrix[J]. Hum Reprod, 2016, 31:427-435.
[17] Soares M, Sahrari K, Chiti MC, et al. The best source of isolated stromal cells for the artificial ovary: Medulla or cortex, cryopreserved or fresh?[J]. Hum Reprod, 2015, 30:1589-1598.
[18] Dath C, Dethy A, Van LA, et al. Endothelial cells are essential for ovarian stromal tissue restructuring after xenotransplantation of isolated ovarian stromal cells[J]. Hum Reprod, 2011, 26:1431-1439.
[19] Zhang Z, Wang Z, Liu SM. Pore size, tissue ingrowth, and endothelialization of small-diameter microporous polyurethane vascular prostheses[J]. Biomaterials, 2004, 25:177-187.
[20] Perets A, Baruch Y, Weisbuch F, et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibro-blast growth factor microspheres[J]. Reprod Biol Endocrinol, 2003, 65:489-497.
[21] Soares M, Saussoy P, Sahrari K, et al. Is transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?[J]. J Assist Reprod Genet, 2015, 32:597-606. |
